英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
ossuarium查看　ossuarium　在百度字典中的解释百度英翻中〔查看〕
ossuarium查看　ossuarium　在Google字典中的解释Google英翻中〔查看〕
ossuarium查看　ossuarium　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • PD-1 PD-L1 pathway: current researches in cancer - PMC
    Cancer immunotherapy has been accompanied by promising results over the past few years Programmed Cell Death Protein 1 (PD-1) plays a vital role in inhibiting immune responses and promoting self-tolerance through modulating the activity of T-cells,
  • Immune Checkpoint Inhibitors - NCI - National Cancer Institute
    Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause
  • PD-L1: From cancer immunotherapy to therapeutic implications . . .
    The PD-L1 PD-1 signaling pathway is the gold standard for cancer immunotherapy Therapeutic antibodies targeting PD-1, such as nivolumab (Opdivo) and pembrolizumab (Keytruda), and PD-L1, including atezolizumab (Tecentriq), durvalumab (Imfinzi), and avelumab (Bavencio) have received Food and Drug Administration approval and are currently being used to treat various cancers Traditionally, PD-L1
  • PD-1 and PD-L1 inhibitors - Wikipedia
    The concept of blocking PD-1 and PD-L1 for the treatment of cancer was first published in 2001 [6] Pharmaceutical companies began attempting to develop drugs to block these molecules, and the first clinical trial was launched in 2006, evaluating nivolumab As of 2017, more than 500 clinical trials involving PD-1 and PD-L1 inhibitors have been conducted in more than 20,000 patients [7] By the
  • Targeting PD-1 PD-L-1 immune checkpoint inhibition for cancer . . .
    It was observed that the blockage of PD-1 PD-L1 binding overturned the exhausted T-cells leading to efficient killing of cancer cells and displayed tremendous success in cancer immunotherapy of various melanomas, breast, and lung cancers etc
  • Immune Checkpoint Inhibitors and Their Side Effects
    Immune checkpoint inhibitors, like PD-1 or PD-L1 inhibitors, are treatments that help the immune system recognize and attack cancer cells Learn more here
  • (PDF) JAK inhibition in PD-1 immunotherapy and tumor . . .
    Targeting the programmed cell death 1 (PD-1) PD-L1 axis has revolutionized cancer therapy; however, the durability of clinical responses is frequently compromised by chronic inflammation and an
  • Teriflunomide modulates the PD-1 PD-L1 axis and enhances . . .
    Teriflunomide is highlighted as a promising immune checkpoint modulator that targets the PD-1 PD-L1 axis to promote CD8+ T-cell-mediated antitumor immunity and is a readily translatable therapeutic for enhancing cancer immunotherapy in CRC Inhibitors that target the programmed cell death protein 1 (PD-1) programmed death-ligand 1 (PD-L1) immune checkpoint pathway have revolutionized cancer
  • AI Validates PD-L1 Scoring in NSCLC: Blueprint Study Revisited
    AI-based PD-L1 scoring shows high agreement with pathologists in NSCLC, improving reproducibility and supporting its role in immunotherapy biomarker assessment





中文字典-英文字典  2005-2009